CareLit · DOI-Nachweis · Pneumologie
Phase III study of canakinumab (ACZ885) as adjuvant therapy in patients with surgically resected NSCLC
DOI 10.1055/s-0039-1678200
Bibliografische Angaben
Nachweis in CareLit
Autor:innenM Thomas, P Christopoulos, EB Garon, A Ardizzoni, F Barlesi, BC Cho, P De Marchi, Y Goto, S Lu, L Paz-Ares, DR Spigel, A Kay, P Cazorla Arratia, J Baum, YY Lau, C Zheng, JCH Yang
ZeitschriftPneumologie
AusgabeS 01 S 01/2019
Jahrgang / SeitenJg. 73
Kernaussage aus der Literatur
Abstract-Vorschau
Phase III study of canakinumab (ACZ885) as adjuvant therapy in patients with surgically resected NSCLC
Zitieren
Zitierempfehlung
M Thomas, P Christopoulos, EB Garon, A Ardizzoni, F Barlesi, BC Cho, P De Marchi, Y Goto, S Lu, L Paz-Ares, DR Spigel, A Kay, P Cazorla Arratia, J Baum, YY Lau, C Zheng, JCH Yang (2019) Phase III study of canakinumab (ACZ885) as adjuvant therapy in patients with surgically resected NSCLC. Pneumologie, 73 (S 01 S 01). https://doi.org/10.1055/s-0039-1678200
Mit CareLit weiterarbeiten